Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
In Brief

Angela Yoon named director of MUSC Hollings Cancer Center Biorepository and Tissue Analysis Shared Resource

Angela J. Yoon was named director of the MUSC Hollings Cancer Center Biorepository and Tissue Analysis Shared Resource, effective Dec. 1; she will oversee a growing collection of cancer-associated biospecimens that allow researchers to translate Biological discoveries into prevention, diagnosis and treatment of cancer.
December 08, 2023
Vol.49 No.45
In Brief

MUSC Hollings head and neck team awarded $3.5M to reduce delays in care

A multidisciplinary team at MUSC Hollings Cancer Center, led by Evan Graboyes, was awarded a $3.5 million grant to test an approach for reducing delays in care for head and neck cancer patients.
September 15, 2023
Vol.49 No.34
In Brief

MUSC Hollings’s Raymond N. DuBois inducted as a fellow into the Royal College of Physicians

Raymond N. DuBois, director of MUSC Hollings Cancer Center, was inducted as a fellow into the Royal College of Physicians. 
July 28, 2023
Vol.49 No.30
In Brief

Travis Poole named associate director of research administration at MUSC Hollings

Travis Poole was named associate director of research administration at MUSC Hollings Cancer Center. 
January 27, 2023
Vol.49 No.04
FreeIn Brief

Nicholas Shungu named associate director for DEI at MUSC Hollings

Nicholas Shungu was named associate director for diversity, equity, and inclusion at MUSC Hollings Cancer Center. 
August 05, 2022
Vol.48 No.31

Posts navigation

Previous12

Trending Stories

  • Trump administration is removing the mainstays of NCI and the federal government’s cancer program
    Peer review, registries, and evidence-based patient information take a big hit
  • NIH eliminates the NCI Board of Scientific Advisors
    Over its 28 year history, BSA shaped NCI-funded extramural science
  • An opportunity for Trump: Position U.S. cancer science to lead the world
  • In the Headlines: “There’s no one to stand up for NCI right now.”
  • Bhattacharya cancels NIH all-hands meeting
  • The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
    In a time of uncertainty, “react to the knowns, not the fear”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account